SCHEMBL1626773

SCHEMBL1626773

CC1(C(=O)O)CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11246632 1.00
SCHEMBL1265631 1.00
SCHEMBL7385907 0.93 FFAR3 (0.39)
SCHEMBL15114541 0.93 FFAR3 (0.39)
SCHEMBL16369943 0.91 FFAR3 (0.37)
Hydrochloric Acid SCHEMBL10338057 0.91 FFAR3 (0.37)
SCHEMBL16369946 0.91 FFAR3 (0.37)
SCHEMBL24780845 0.83
SCHEMBL9658533 0.83 GLS (0.40)
SCHEMBL13317636 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4038045-A1 CRYSTALLINE FORMS OF BEMPEDOIC ACID Synthon B.V. (NL) 2022-08-10 EP claimed
CN-113354551-A Preparation method of amide compound 东莞市东阳光动物保健药品有限公司 2021-09-07 CN claimed
EP-2200440-B1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS CRESTONE INC (US) 2017-07-19 EP claimed
CN-101883778-A Steroidal [3, 2-C] pyrazole compounds, with glucocorticoid activity ASTRAZENECA AB 2010-11-10 CN claimed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP claimed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO claimed
CN-116507610-B Herbicidal malonamides 巴斯夫欧洲公司 2026-05-19 CN disclosed
US-20250313574-A1 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-10-09 US disclosed
US-20250257076-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2025-08-14 US disclosed
US-20250236608-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION 2025-07-24 US disclosed
EP-4539840-A1 KINASE MODULATORS AND METHODS OF USE THEREOF Neuron23, Inc. (US) 2025-04-23 EP disclosed
EP-4251609-B1 HERBICIDAL MALONAMIDES BASF SE (DE) 2025-04-23 EP disclosed
EP-4536653-A2 SIALIC ACID DERIVATIVES AND METHODS OF USING SAME Eisai R&D Management Co., Ltd. (JP) 2025-04-16 EP disclosed
US-4293556-A Analgesic 2-(2-alkoxy-ethyl)-2'-hydroxy-6,7-benzomorphans and salts thereof BOEHRINGER INGELHEIM GMBH (DE) 1981-10-06 US disclosed
EP-0006449-A1 2-(2-Alkoxyethyl)-2'-hydroxy-6.7-benzomorphane derivatives, their acid addition salts, medicaments containing them and process for their preparation C.H. BOEHRINGER SOHN (DE) 1980-01-09 EP disclosed
US-4138577-A 11-Deoxy-cis-4,5-didehydro-ω-aryl-PGF compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4138575-A 11-Deoxy-16-phenoxy-PGF compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4138576-A 11-Deoxy-2,2-difluoro-ω-aryl-PGF compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4138573-A 11-Deoxy-2,2-difluoro-ω-aryl-PGE compounds THE UPJOHN COMPANY (US) 1979-02-06 US disclosed
US-4126754-A 11-Deoxy-cis-4,5-didehydro-ω-aryl-PGE compounds THE UPJOHN COMPANY (US) 1978-11-21 US disclosed